Effects of bisoprolol and nebivolol on the left ventricular diastolic function in patients (pts) with COPD and stable angina. Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020
The characterization of diastolic function of the right ventricle in patients with COPD combined with congestive heart failure (CHF) Source: International Congress 2014 – Predictors Year: 2014
Is there benefit from proactive case-detection of left ventricular systolic dysfunction (LVSD) using BNP in patients with advanced COPD? Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016
Right ventricular diastolic function in patients with COPD and heart failure, depending on endothelial function Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Safety of nebivolol and bisoprolol in patients (pts) with COPD and stable angina. Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018
Increased frequency of supraventricular (SVPC) and ventricular arrhythmias (PVC) in stable patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Management of COPD in primary care Year: 2014
The evaluation of local right ventricle contractility in patients with COPD Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013
Clinical characteristics of COPD patients suspected of left ventricular diastolic dysfunction Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
COPD: Left ventricular dysfunction, systemic inflammation and endothelial dysfunction Source: International Congress 2014 – Markers Year: 2014
Physical and psychological impairments in COPD patients with and without reduced left ventricular ejection fraction Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases Year: 2015
COPD and co-existent chronic heart failure (CHF): Response to pulmonary rehabilitation (PR) Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016
Carvedilol, bisoprolol, and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary disease: A nationwide population-based study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015
Pulse wave velocity in patients with COPD comorbid with arterial hypertension Source: International Congress 2014 – COPD exacerbations Year: 2014
Cognitive dysfunction is greater in patients hospitalised with COPD exacerbations than with worsening heart failure Source: International Congress 2014 – Markers Year: 2014
Resistin, 8-isorpostanes and stress right ventricular diastolic dysfunction - predictors for exacerbations in non-severe chronic obstructive pulmonary disease patients Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease Year: 2021
Right ventricular (RV) diastolic function in patients with pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 26s Year: 2002
The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD treatment Year: 2013
Continuous indacaterol treatment improves autonomic cardiac regulation in COPD patients Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Right ventricular response during exercise in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Clinical exercise physiology in health and disease Year: 2015
Evaluation of arrhythmia frequency in patients with COPD Source: International Congress 2015 – Different data in COPD Year: 2015